108 related articles for article (PubMed ID: 34481801)
1. Hospital Volume Predicts Guideline-Concordant Care in Stage III Esophageal Cancer.
Adhia AH; Feinglass JM; Schlick CJR; Merkow RP; Bilimoria KY; Odell DD
Ann Thorac Surg; 2022 Oct; 114(4):1176-1182. PubMed ID: 34481801
[TBL] [Abstract][Full Text] [Related]
2. Adherence to quality measures improves survival in esophageal cancer in a retrospective cohort study of the national cancer database from 2004 to 2016.
Adhia A; Feinglass J; Schlick CJ; Odell D
J Thorac Dis; 2020 Oct; 12(10):5446-5459. PubMed ID: 33209378
[TBL] [Abstract][Full Text] [Related]
3. Variation in lymph node examination after esophagectomy for cancer in the United States.
Merkow RP; Bilimoria KY; Chow WB; Merkow JS; Weyant MJ; Ko CY; Bentrem DJ
Arch Surg; 2012 Jun; 147(6):505-11. PubMed ID: 22351873
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Nationwide Trends in Nodal Sampling Guideline Adherence for Gastric Cancer: 2005-2017.
Mahenthiran AK; Logan CD; Janczewski LM; Valukas C; Warwar S; Silver CM; Feinglass J; Merkow RP; Bentrem DJ; Odell DD
J Surg Res; 2023 Nov; 291():514-526. PubMed ID: 37540969
[TBL] [Abstract][Full Text] [Related]
5. Sociodemographic and Facility-Related Disparities in the Delivery of Guideline-Concordant Therapy Among Patients With Esophageal Adenocarcinoma.
da Costa WL; Camp ER; Thrift AP
JCO Oncol Pract; 2022 Jul; 18(7):e1181-e1197. PubMed ID: 35436147
[TBL] [Abstract][Full Text] [Related]
6. Institutional factors associated with adherence to quality measures for stage I and II non-small cell lung cancer.
Khorfan R; Cooke DT; Meguid RA; Backhus L; Varghese TK; Farjah F; Bilimoria KY; Odell DD;
J Thorac Cardiovasc Surg; 2021 Sep; 162(3):649-660.e8. PubMed ID: 34144822
[TBL] [Abstract][Full Text] [Related]
7. Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: assessment of 987 hospitals.
Merkow RP; Bilimoria KY; McCarter MD; Chow WB; Ko CY; Bentrem DJ
Ann Surg Oncol; 2012 Feb; 19(2):357-64. PubMed ID: 21769460
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.
Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH
Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991
[TBL] [Abstract][Full Text] [Related]
9. University hospital status and surgeon volume and risk of reoperation following surgery for esophageal cancer.
Kauppila JH; Wahlin K; Lagergren P; Lagergren J
Eur J Surg Oncol; 2018 May; 44(5):632-637. PubMed ID: 29548804
[TBL] [Abstract][Full Text] [Related]
10. Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy.
Samson P; Puri V; Broderick S; Patterson GA; Meyers B; Crabtree T
Ann Thorac Surg; 2017 Feb; 103(2):406-415. PubMed ID: 28024648
[TBL] [Abstract][Full Text] [Related]
11. How many lymph nodes should be dissected in esophagectomy with or without neoadjuvant therapy to get accurate staging?
Zhan C; Shi Y; Jiang W; Sun F; Li M; Lu T; Yin J; Ma K; Yang X; Wang Q
Dis Esophagus; 2020 Jan; 33(1):. PubMed ID: 30997490
[TBL] [Abstract][Full Text] [Related]
12. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
[TBL] [Abstract][Full Text] [Related]
13. Lymph Node Harvest as a Measure of Quality and Effect on Overall Survival in Esophageal Cancer: A National Cancer Database Assessment.
Dudash MJ; Slipak S; Dove J; Hunsinger M; Wild J; Shabahang M; Arora TK; Blansfield JA
Am Surg; 2019 Feb; 85(2):201-205. PubMed ID: 30819299
[TBL] [Abstract][Full Text] [Related]
14. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.
Jang HJ; Lee HS; Kim MS; Lee JM; Zo JI
Ann Thorac Surg; 2011 Sep; 92(3):1091-7. PubMed ID: 21704967
[TBL] [Abstract][Full Text] [Related]
15. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
[TBL] [Abstract][Full Text] [Related]
16. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
17. Variation in Diagnosis, Treatment, and Outcome of Esophageal Cancer in a Regionalized Care System in Ontario, Canada.
Habbous S; Yermakhanova O; Forster K; Holloway CMB; Darling G
JAMA Netw Open; 2021 Sep; 4(9):e2126090. PubMed ID: 34546371
[TBL] [Abstract][Full Text] [Related]
18. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing quality of lymphadenectomy in minimally invasive esophagectomy: a US-based analysis.
Odetoyinbo K; Bachman K; Worrell S; Gray K; Linden P; Towe C
Dis Esophagus; 2022 Oct; 35(10):. PubMed ID: 35039833
[TBL] [Abstract][Full Text] [Related]
20. The Relative Survival Impact of Guideline-Concordant Clinical Staging and Stage-Appropriate Treatment of Potentially Curable Non-Small Cell Lung Cancer.
Meadows-Taylor MB; Faris NR; Smeltzer MP; Ray MA; Fehnel C; Akinbobola O; Ariganjoye F; Patel A; Pacheco A; Mehrotra A; Fox R; Optican R; Tonkin K; Machin J; Wright J; Robbins ET; Osarogiagbon RU
Chest; 2022 Jul; 162(1):242-255. PubMed ID: 35122751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
